quarta-feira, 13 de julho de 2016

Arthrocentesis and Therapeutic Joint Injection: An Overview for the Primary Care Physician

Arthrocentesis and
Therapeutic Joint
Injection: An Overview
for the Primary
Care Physician
R. Brian Bettencourt, MD*, Michael M. Linder, MD
Arthrocentesis is a safe and useful primary care procedure. Joint aspiration and
injection can be both diagnostic and therapeutic; it can allow identification and treatment of pathologic agents as well as provide significant pain relief. There are
numerous conditions affecting adults and children that may lead to mono- or polyarticular joint swelling. Causes can range from rheumatic to infectious to idiopathic, and
thorough investigations of each may require specific serologic studies or specialist
consultation. This review provides current and practical recommendations for
evaluation and localized treatment of effusive joint pain by the primary care physician.
INDICATIONS AND CLINICAL EVIDENCE
Multiple indications exist for arthrocentesis. Synovial fluid aspiration may be indicated
in any joint with an effusion, or even in a normal-appearing joint when the diagnosis is
in doubt. There are many causes for joint effusions in adults and children (Table 1).
When evaluating a synovial effusion of unknown origin, aspiration is indicated.1 Arthrocentesis is essential for the diagnosis and management of the acute hot red joint,
which may be a medical emergency secondary to the morbidity and mortality associated with septic arthritis.2
With or without subsequent therapeutic injection, arthrocentesis of a joint effusion
can often provide pain relief. Traumatic injury to a joint may cause hemarthrosis and
effusions ranging from small to large, tense and painful. Aspiration of large traumatic
effusions can ease pain and allow for increased range of motion.
The authors have nothing to disclose.
Family Medicine Residency Program, University of South Alabama, 1504 Springhill Avenue,
Room 3414, Mobile, AL 36604, USA
* Corresponding author.
E-mail address: rbettencourt@usouthal.edu
KEYWORDS
Arthrocentesis Joint Effusion Steroid Injection
Prim Care Clin Office Pract 37 (2010) 691–702
doi:10.1016/j.pop.2010.07.002 primarycare.theclinics.com
0095-4543/10/$ – see front matter 2010 Published by Elsevier Inc.
CONTRAINDICATIONS
Diagnostic arthrocentesis has few contraindications. Periarticular cellulitis or infection
is considered an absolute contraindication to joint aspiration. The concern is that the
joint might be seeded by organisms of the overlying skin infection during percutaneous access. However, if the joint is believed to be the cause of the infection,
diagnostic aspiration should be performed. The attempt should be made through an
area of appropriately prepared uninvolved skin. Joint access through an area of
irregular or disrupted skin, such as in psoriasis, should be avoided because of
increased numbers of colonizing bacteria in these areas.3
Septicemia has been considered a contraindication to arthrocentesis secondary to
the possibility of introducing organisms into the joint space. The morbidity and
mortality associated with a septic joint are substantial. Joints with a high suspicion
for bacterial infection should probably undergo aspiration regardless of the presence
of septicemia. Septicemia may be the initial finding in young children with bacterial
arthritis. The risk of leaving a septic joint improperly treated seems to outweigh the
theoretic risk of seeding.
In patients with bleeding disorders or who are taking anticoagulants, joint aspiration
is contraindicated. Inducing traumatic hemarthrosis is a concern. However, the risk of
significant hemarthrosis after arthrocentesis is low. At least 1 study showed that even
in patients on warfarin therapy with international normalized ratios of 4.5, there was not
an increased risk of significant bleeding.4
COMPLICATIONS OF ARTHROCENTESIS
Generally, the most feared complication of arthrocentesis is iatrogenic infection.
Although there is a lack of recent large studies, iatrogenic infection after arthrocentesis
seems rare but remains a possible complication. In studies in which injection sites were
stained before percutaneous needle access of a joint, investigators were able to arthroscopically identify transferred fragments of the stained skin within the joint in most
cases.5 Although iatrogenic infection seems rare, these findings serve to reinforce
the importance of sound aseptic technique and skin preparation during the procedure.
SYNOVIAL FLUID AND EFFUSIONS
There are numerous causes for joint effusions. The gross appearance of synovial fluid
can provide clues related to the type and degree of joint pathology.
Table 1
Differential of an acute joint with effusion
Infectious Osteoarthritis
Bacterial Rheumatologic
Viral Rheumatoid arthritis
Lyme disease Juvenile idiopathic arthritis
Bacterial endocarditis sequelae Systemic lupus erythematosus
Crystalline disease Spondyloarthropathy
Gout Transient synovitis
Pseudogout (CPPD) Systemic vasculitis
Hydroxyapatite Neoplastic
Hemarthrosis Pigmented villonodular synovitis
Coagulopathy Metastatic disease
Trauma Idiopathic
Data from Refs.1,2,27,28,32–38
692 Bettencourt & Linder
Historically, 1 step in clinical diagnosis has been to assign results of synovial fluid
visual inspection to 1 of 5 categories: normal, inflammatory, noninflammatory, hemorrhagic, or septic (Table 2). Each category can have an association with a specific
disease process.
On visual inspection, inflammatory-appearing fluid may suggest crystalline joint
disease or any number of rheumatologic conditions. Noninflammatory appearing fluid
may be present in joints with osteoarthritis. It is important to remember during clinical
decision making that there can be significant overlap between categories.
Normal synovial fluid is clear, colorless to pale yellow, and highly viscous. Fluid of an
inflammatory source ranges from yellow to greenish yellow and may be white in the
crystalline arthropathies (eg, gout, calcium pyrophosphate dehydrate [CPPD]). Septic
joints can yield greenish, gray, or purulent fluid. Red, rusty, or brownish fluid suggests
hemarthrosis. The viscosity and turbidity of synovial fluid varies with the cause.
Turbidity can be expected to increase with the degree of inflammation.3
Viscosity can be variable. The “string sign” has been used as a subjective examination whereby normally viscous fluid dripped out of a syringe stretches to 3 cm in length
before breaking. Inflammation with release of proteolytic enzymes generally
decreases synovial fluid viscosity. However, septic fluid may show increasing
viscosity with increased purulence.
LABORATORY ANALYSIS OF SYNOVIAL FLUID
Laboratory analysis of synovial fluid is the single most important assessment
technique when investigating an effusion of unclear etiology. It is essential in any
investigation of a suspected septic joint. Synovial fluid analysis also allows for
diagnosis of specific crystalline arthropathies, and helps to determine whether the
cause may be inflammatory or noninflammatory.
For formal study, collected synovial fluid can be divided into 4 aliquots. One of the 4
should be a sterile tube with anticoagulant for bacteriologic studies. One tube with ethylenediaminetetraacetic acid should be sent for routine cytology, and another tube
without anticoagulant should be prepared for crystal search and analysis. The remaining fluid may be reserved for other specialized studies if indicated.5
Often the volume of available fluid for study may be limited. Ruling out a septic
etiology is the primary concern when evaluating an effused joint. In such cases,
laboratory analysis of synovial fluid should include a white blood cell (WBC) count
with differential, Gram stain, and culture.
CYTOLOGY
Normal synovial fluid should be nearly free of cells. Samples indicating an inflammatory cause show increasing numbers of leukocytes, with the WBC cutoff of 2000
cells/mL generally accepted as distinguishing noninflammatory from inflammatory
Table 2
Gross visual inspection of synovial fluid aspirate
Normal Noninflammatory Inflammatory Infectious Hemorrhagic
Appearance Clear to
pale yellow
Clear,
yellow
Cloudy,
yellow
Purulent or
cloudy
Bloody
Viscosity High High Low Variable Variable
Data from Refs.1,2,27,28,32–38
Arthrocentesis and Therapeutic Joint Injection 693
conditions. The widely accepted WBC count defining septic synovial fluid has
classically been greater than 50,000 WBC/mL.6 However, in one recent study of
culture-positive synovial fluid aspirates, 39% had synovial WBC counts of less than
50,000 cells/mL.7 Another similar study found greatly increased likelihood for septic
arthritis with synovial WBC counts equal to or greater than 25,000 cells/mL, but
a polymorphonuclear leukocyte count less than 90% significantly decreased the likelihood of a septic cause. Thus 25,000 cells/mL may be a more accurate threshold if
there is concern regarding septic arthritis.8
Additional information regarding synovial fluid findings can be found in Table 3.
CRYSTAL DETECTION
Synovial fluid analysis is useful in establishing a diagnosis of crystal-induced arthritis.
The CPPD of pseudogout appear as positively birefringent rhomboid crystals under
polarized microscopy. Definitive diagnosis of CPPD generally requires the addition
of characteristic joint findings on imaging. The monosodium urate crystals of gout
are negatively birefringent under polarized light microscopy, and their presence is
diagnostic of gout.
GRAM STAIN AND CULTURE
Studies to evaluate for microbes are essential in the evaluation of an effusion of
unknown cause. The sensitivity of the Gram stain in bacterial arthritis is generally
50% to 70%, with the exception being gonococcal arthritis (perhaps <10%).9,10
Cultures are generally positive in most cases of bacterial arthritis, the exception again
being gonococcal arthritis (<50%).11,12 Even in joint aspirates from patients with
confirmed crystal-induced arthritis, one study reported that 1.5% had concomitant
synovial bacterial infections.13 In the setting of an unexplained joint effusion the synovial fluid investigation should include Gram stain and culture even if the fluid appears
inflammatory.
Table 3
Synovial fluid analysis
Normal Noninflammatory Inflammatory Infectious
Culture Negative Negative Negative Often
positive
WBC/mL <200 <200–2000 200–50,000 >25,000–
50,000
Polymorphonuclear
leukocytes (%)
<25 <25 >50 >50–90
Crystals Negative Negative Positive
or none
None
Associated
conditions
Osteoarthritis Rheumatic diseases,
crystalline
diseases,
spondyloarthropathies,
systemic lupus
erythematosus
Septic
arthritis
Data from Refs.1,2,3,6–8,27,28,32–38
694 Bettencourt & Linder
BACTERIAL ARTHRITIS
Intraarticular corticosteroid injection is contraindicated in cases of suspected bacterial
arthritis. Corticosteroids inhibit the ability of the immune system to fight off infection.
The patient with septic arthritis generally requires inpatient care with intravenous antibiotics and orthopedic specialist consultation. Specifics and management are
discussed elsewhere in this issue.
INJECTION IN INFLAMMATORY ARTHRITIS
Intraarticular corticosteroids injections are commonly used to treat inflammatory joint
conditions such as the rheumatoid and crystal-induced arthropathies. Much of the
experience in this area has been with conditions such as rheumatoid arthritis, juvenile
idiopathic arthritis, psoriatic arthritis, and reactive arthritis. There are anecdotal
reports of use in less common conditions such as sarcoidosis and systemic lupus
erythematosus, but there seem to be no large-scale studies using intraarticular
steroids in those conditions.
Corticosteroid injections are frequently used in the treatment of rheumatoid arthritis
as an adjunct to disease-modifying drug therapy. Several large studies support their
efficacy and safety. Removal of joint fluid by aspiration before instilling the steroid
has been shown to improve short-term outcomes.14 Serial injection in inflamed rheumatic joints has been shown to be superior to systemic steroids, to be helpful in
obtaining clinical remission, and to reduce radiographic progression of disease.15,16
The mainstay of treatment in most crystal-induced arthritis is intervention to control
serum uric acid levels and oral analgesia. However, therapeutic injection is an effective
treatment of exacerbations. Intraarticular corticosteroids generally lead to faster resolution, and most patients can anticipate relief within 24 to 48 hours of administration.3
INJECTION IN NONINFLAMMATORY ARTHRITIS
Osteoarthritis is typified by gradual degeneration of articular cartilage with the development of joint pain, stiffness, and losses in range of motion. The knee is the most
commonly affected joint. When standard therapies such as physical therapy and
oral analgesics do not provide adequate relief, intraarticular corticosteroids are
commonly used to treat pain and swelling associated with osteoarthritis. Generally,
in those who show a response, maximum benefit seems to last from 1 to 6 weeks,
with waning effect by 12 weeks after injection.17 As with the treatment of rheumatoid
arthritis, there seems to be better response to therapeutic injection if fluid is first aspirated from the joint space.7
Hyaluronic acid (HA) derivatives can be used to treat pain associated with osteoarthritis of the knee and have been the subject of much study in recent years. These
preparations can be delivered as a single dose or as a series of 3 to 5 weekly
injections. Some meta-analysis reviews suggest that HA treatments may have
a modest pain relief advantage over oral nonsteroidal anti-inflammatory drugs
(NSAIDs). One recent review that compared the efficacy of corticosteroid versus HA
over time suggested that steroid injection may give better results from week 0 to
week 4, but that an HA showed better efficacy from week 8 to week 26.18 Choice of
therapy is dependent on individual practitioner experience and preference.
CORTICOSTEROID PREPARATIONS
There seems to be no consensus on the type of steroid that is best used for therapeutic joint injection. Commonly used agents are triamcinolone preparations
Arthrocentesis and Therapeutic Joint Injection 695
(Kenalog, Aristospan), methylprednisolone (Depo-Medrol), and betamethasone
(Celestone Soluspan). There seems to be significant regional variation in choice of
steroid.19 There is anecdotal evidence that use of betamethasone (Celestone
Soluspan) may result in better outcomes (Box 1). Table 4 identifies how much volume
of this preparation each joint tolerates.
Current standard practice is to include a volume of local anesthetic during therapeutic injection. This addition can give the patient fast temporary pain relief, and the
added fluid volume is believed to help distribute the steroid within the joint. Depending
on the size of the joint, between 3 and 7 mL of 1% lidocaine can be included with
intraarticular steroid injections.
RISKS AND COMPLICATIONS
Although the incidence is low, iatrogenic infection is considered the primary risk
associated with intraarticular injection. Estimates of actual risk vary by an order of
magnitude from 1 in 10,000 to 1 in 100,000.20,21 This risk, as well as warning signs
and symptoms, should be included in an informed consent discussion with the patient
before the procedure.
Redness and swelling that can be mistaken for signs of infection rarely occur after
the procedure. This phenomenon, termed postinjection flare, can have onset a few
hours to 2 days after an injection. Believed to be an inflammatory reaction to the
steroid crystals themselves, postinjection flare is estimated to occur in 1% to 6% of
such therapeutic injections.3 The effect is self limited and usually responds to application of ice packs. If not contraindicated, oral NSAIDs can be given for a few days to
decrease the probability of postinjection flare.22,23
There is evidence that local steroid injections may exert some systemic effects. One
study documented decreases in plasma cortisol lasting 2 to 7 days after a single injection.23 However, the degree and duration of adrenal suppression from an intraarticular
injection of depot steroid is less than that seen from an equivalent intramuscular
Box 1
Steps for combined intraarticular aspiration and injection
1. Discuss risks and benefits with patient and obtain informed consent
2. Prepare equipment and medication
3. Identify and mark appropriate landmarks and/or point of needle placement
4. Clean overlying skin using povidone-iodine (Betadine) or isopropyl alcohol
5. Use cooling spray or local anesthetic for patient comfort (as needed)
6. Select appropriate length and gauge of needle
7. Introduce needle into intraarticular space
8. Gently aspirate fluid
9. Anchor needle with hemostat to prevent migration from the intraarticular space
10. Remove aspirate syringe and replace with syringe containing steroid and/or anesthetic for
injection
11. Introduce medication into the intraarticular space
12. Remove needle and apply dressing
13. Provide postprocedural counseling
14. Monitor patient for adverse reactions
696 Bettencourt & Linder
dose.24,25 Patients who are diabetic should closely monitor their serum glucose
measurements for 2 weeks following an intraarticular injection because systemic
effects could cause temporary increases. Some patients may experience transient
flushing or diaphoresis after procedure. This reaction is presumably secondary to
systemic effect or possibly from a reaction to preservatives in the steroid preparation.3
There has been discussion regarding steroid-induced cartilaginous arthropathy with
frequent injection of the same joint. There is a lack of consensus in the literature
regarding frequency of administration, and concerns about corticosteroid-mediated
arthropathy persist. Most large studies do not support this as a significant risk in either
rheumatoid or osteoarthritis treatment. A prudent approach seems to be applying
corticosteroid injection to an individual joint no more than 4 times a year. Although
the adjunctive use of a local anesthetic mixed in with the steroid for injection has
become standard, recent animal studies have suggested that chondrocyte viability
may be adversely affected by exposure to common local anesthetics in a dose-dependent manner.26,27 There are no human studies at this time but future modifications of
this currently common practice may occur as a result.
TECHNIQUE
Injection of the shoulder, elbow, or knee can be considered an adjunctive therapy.
Generally, it may be used after other appropriate therapeutic interventions have
been undertaken. These interventions include oral pain relievers, physical therapy,
and in the case of rheumatoid arthritis should not replace disease-modifying agents.
Arthrocentesis and injection are best performed using sterile surgical gloves and
aseptic technique. An 18- to 22-gauge needle should be used for medium to large
joints, and a syringe of up to 60 mL volume (or rarely 2 syringes for a large knee
effusion) should be available. If possible the patient should be placed in a comfortable
supine or upright position. The involved area should be prepared with povidone-iodine
(Betadine) and draped. One key to success in accessing a joint space is a solid understanding of the anatomy and associated landmarks of the joint; a quick review is never
detrimental.
There are several approaches to skin anesthesia before arthrocentesis. Subcutaneous 1% lidocaine delivered through a high-gauge needle can be used at the point
of injection to lessen discomfort. When treating children, pretreatment with topical
eutectic lidocaine/prilocaine cream may or may not be effective.28 Ethyl chloride spray
is an excellent option. It is a rapidly evaporating coolant that provides good superficial
anesthesia at the point of injection.
Interest in ultrasound guidance during joint aspiration and injection has increased in
recent years. It has previously been reported to increase the rate of successful
aspiration in joint spaces that are difficult to access. Other investigators have asserted
that in most uncomplicated cases the use of standard anatomic landmarks results in
correct needle placement. Recent publications support the usefulness of sonographic
Table 4
Volume of preparation tolerated by joint
Joint/Area Betamethasone (mL) Lidocaine (1%) (mL) Hydrocortisone Equivalents (mg)
Knee 2–3 5–7 300–450
Shoulder 1–2 5–7 150–300
Subacromial 1–2 5–7 150–300
Elbow 1–2 3–5 150–300
Arthrocentesis and Therapeutic Joint Injection 697
guidance in large joint aspiration and injection. Studies have shown greater aspirate
fluid volume with sonographic needle guidance during arthrocentesis, and there is
increasing evidence of intraarticular injection accuracy and decreased procedural
pain over anatomic landmark placement.29
Aspiration of fluid should be performed before corticosteroid injection, not only to
improve therapeutic outcomes as described earlier, but to help verify intraarticular
needle placement. Removal of the aspirate syringe and replacement with a syringe
with the corticosteroid preparation can be cumbersome. To ensure continued intraarticular placement, and to decrease the amount of needle tip movement, many
physicians secure the needle with a hemostat during changeover.
KNEE
The knee is the most commonly and easily aspirated joint. There are many different
successful techniques. It may be accessed via a lateral, medial, or anterior approach,
with the patient either supine and the joint in nearly full extension, or with the patient
sitting upright with the leg dependent and knee in 90 flexion. Many find that a lateral
approach is easiest. Position the patient supine in near full knee extension with a rolled
towel under the popliteal space for support when attempting this approach. The knee
is comprised of 2 functional joints: the femoral-tibial and the femoral-patellar joints. A
recess can be palpated approximately 1 to 2 fingerbreadths superior and 1 to 2 fingerbreadths lateral of the superior margin of the lateral patella. The joint can be accessed
with a needle through this recess.22
Before sterile preparation, identify and mark this area of access using either an
indentation in the skin or ink for a guidance mark. After preparation and application
of topical anesthesia, an 18- to 22-gauge needle can be directed at a 45 angle distally
and 45 into the knee (Fig. 1). Advance the needle slowly and purposefully about 1 to
3 cm into the joint space while gently aspirating the syringe.3 Using a free hand to
compress the opposite side of the joint or patella may aid in arthrocentesis.
Care should be taken during the procedure. Striking boney or articular surfaces with
a needle can cause patient discomfort. When fluid flows easily into the syringe, stop
advancement of the needle and continue smooth constant aspiration. The suprapatellar pouch communicates with the joint space, and extends well above the patella. Fluid
aspiration from an effused knee may be further enhanced by applying mild manual
Fig. 1. Lateral approach to knee. Needle placed lateral of the superior margin of the lateral
patella (black outline identifies superior lateral border of patella).
698 Bettencourt & Linder
pressure and milking fluid down from this space. After changeover from the aspiration
syringe to the prepared syringe, the suspension should be introduced slowly and
smoothly.
SHOULDER
The glenohumeral joint is the most mobile joint of the body. It is supported by the joint
capsule and several ligaments and muscles. Therapeutic injection of the shoulder can
be used in treatment of various systemic processes, overuse syndromes, and injuries.
A suspected tear in the rotator cuff is a relative contraindication. The glenohumeral
joint is a small space and accessing it can prove more challenging than the knee.
Landmarks for the procedure include the acromion, the head of the humerus, and
the coracoid process.30
Fig. 2 shows a posterior approach. The patient is positioned upright with the
humerus in a dependent position. Palpation of the posterior area of the shoulder
should reveal a recess found 2 to 3 cm below the posterolateral corner of the
acromion. The needle is introduced and advanced anteromedially and slightly inferiorly. The tip of the needle should be directed at the coracoid process while the syringe
is gently aspirated (Fig. 2). Even after a thorough history and physical examination, the
exact cause of shoulder pain can remain unclear. For ease and practicality, a therapeutic injection into the subacromial space is often beneficial to nearby structures
such as the subdeltoid bursa, subacromial bursa, and rotator cuff tendons.3
To access the subacromial space, the needle is inserted just inferior to the posterolateral acromion. The tip of the needle should be directed toward the contralateral
nipple (Fig. 3). The steroid mixture should flow freely into the space.30 Lack of free
flow may indicate an impacted needle tip, and the needle should be withdrawn slightly.
ELBOW
The elbow joint comprises the articulations of the humerus, the radius, and the ulna.
There is 1 commonly used approach to aspiration and injection of the joint, and
success depends on proper landmark identification. For this procedure the patient
may be placed in a semirecumbent position with the elbow flexed at 45 .
The lateral epicondyle of the humerus, the lateral aspect of the olecranon, and the
head of the radius describe a triangle, the center of which allows percutaneous access
to the elbow joint. The needle is inserted and directed toward the medial epicondyle31
Fig. 2. Posterior approach to the shoulder. Line identifies the posterior and lateral aspects of
the acromion.
Arthrocentesis and Therapeutic Joint Injection 699
(Fig. 4). If bony resistance is encountered, the needle should be pulled back slightly
and redirected. After aspiration, mixture should flow easily into the joint space.
TECHNIQUE
If additional syringes are needed during aspiration or if therapeutic injection is to be
performed, the intraarticular needle may be secured and held steady by application
of a sterile hemostat or other device. This procedure allows changeover of the
syringes while maintaining needle positioning and minimizing excess movement within
the joint space.
On withdrawal of the needle the area should be dressed. Joints with large effusions
may benefit from pressure dressings to decrease reaccumulation of fluid. Relative rest
of the involved joint for 24 to 48 hours after the procedure is commonly recommended.
The procedure, the anticipated course, and plans for follow-up should be discussed
with the patient.
Occasionally, after use of intraarticular anesthetic, the patient may experience an
episode of rebound pain several hours after the procedure. This pain can occur as
the initial anesthetic effect wears off, and can be distressing for the patient. Reviewing
this possibility may spare the patient and physician a concerned late-night phone call.
Fig. 4. Injection of elbow. Circle indicates lateral epicondyle. Upper line is the radial head
and lower line is lateral border of olecranon.
Fig. 3. Injection into the subacromial space. Line indicates posterior and lateral aspect of
acromion. Note direction of needle.
700 Bettencourt & Linder
SUMMARY
Athrocentesis and therapeutic joint injection is a safe, useful, and perhaps underused
primary care procedure. Fluid collection and analysis from a joint with an effusion of
unclear cause is an important part of appropriate management. Treatment with
therapeutic joint injection can give patients significant, rapid, localized pain relief.

Nenhum comentário:

Postar um comentário